GlassScriptPhysician profile
Ruthann F Rees
NPI 1194820753
$1,513.49
in general payments reported to CMS, 2019-2025
22 companies · $53.15 in 2025
The $53.15 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $50.43 · 2021: $310 · 2022: $237 · 2023: $85.76 · 2024: $65.09 · 2025: $53.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $374.72 | 2019-2021 | |
| Merz North America, INC. | $372.62 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $147.26 | 2019 | |
| Novo Nordisk INC | $101.06 | 2019-2022 | |
| Currax Pharmaceuticals LLC | $75.22 | 2019-2023 | Contrave |
| Nalpropion Pharmaceuticals LLC | $61.51 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.85 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $38.46 | 2023-2024 | Myfembree |
| Therapeuticsmd, INC. | $37.97 | 2019 | |
| Radius Health, INC. | $29.32 | 2024 | Tymlos |
| Hologic Sales and Service, LLC | $24.34 | 2023 | Novasure, Myosure Tissue Removal Device |
| Myriad Women'S Health, INC. | $22.94 | 2023 | Myrisk |
| Exeltis, USA INC. | $22.82 | 2025 | Slynd |
| Minerva Surgical, INC | $21.48 | 2019 | |
| Mallinckrodt Enterprises LLC | $20.95 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $18.80 | 2024 | NP Thyroid 60 |
| Vivus LLC | $18.72 | 2019 | |
| Lilly USA, LLC | $16.69 | 2025 | Zepbound |
| Myovant Sciences INC. | $15.62 | 2021 | |
| Lupin INC. | $14.16 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $13.64 | 2025 | |
| Allergan, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruthann Rees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.